explore -WSS

explore

author：knowledge 2025-10-02 00:40:01 - browse：168

Two boxes of Humira and a Humira pen on the side — first opinion coverage from STAT — David J. Phillip/AP

It’s been one year since the launch of the first adalimumab biosimilar for Humira in the United States, which was followed by eight additional adalimumab biosimilar launches. These nine FDA-approved products offer lower-cost alternatives to the world’s bestselling drug, Humira, used to treat rheumatoid arthritis, Crohn’s disease, and other autoimmune disorders. This made 2023 a watershed year for millions of U.S. patients paying too much for their necessary medications.

But so far, that vision hasn’t come to fruition, because policymakers haven’t taken the action necessary to be sure these lower-cost products are accessible for patients. If they fail to act, the U.S. health care system could lose up to $133 billion in savings and leave patients without access to the medicines they need.

Biosimilars are safe and effective treatments referencing biologic drugs. They are market disruptors, forcing lower prices for biologic medicines. The cost savings from reference biologic products begins almost immediately when biosimilars enter the market and continues over time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Humans aren't the only ones with an imagination. Rats have it too

hotspot

WSS

Children’s Hospital revives plan for pedestrian bridge

Travis Kelce and the trap of celebrity vaccine endorsements

Virtual repurposing can help discover new uses for existing drugs

CDC panel: People 65 and older should get a Covid spring booster shot

Explaining an after

Medicare isn't yet testing food as medicine

leisure time

explore

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Coloradans with cystic fibrosis could lose access to Trikafta

State Dept. review finds Biden bears some blame for Afghanistan failures

Doctor of U.S. President Joe Biden says he is fit for duty

Medicare details structure of new drug price negotiation program

Childhood vaccination ad campaign launches in the U.K.

Medicare details structure of new drug price negotiation program

Elisabeth Bik tackles the widespread issue of research misconduct

Guidelines to prevent youth baseball injuries need more muscle

Childhood vaccination ad campaign launches in the U.K.

Wikipedia

Color Health wants to make cancer screenings convenient

Kidney transplant patients stopped immunosuppressants in trial

Medicare proceeds with plan to claw back hospital funds

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Pfizer is about to make a big push in cancer. Will investors listen?

'Vaccine

Wikipedia

focus

hotspot

knowledge